In patients with liver failure, the source of an upper GI blee | Surgery videos & books

In patients with liver failure, the source of an upper GI bleed is esophageal varices in 50%, gastritis in 30%, and duodenal ulcers in only about 10%. Esophageal variceal bleeding is a potentially fatal complication of portal hypertension. The initial management should include fluid resuscitation and replacement of blood and clotting factors as needed. The second step is to control the source of bleeding. Medical management may include vasopressin or octreotide. Once the patient is stabilized, endoscopic evaluation of the bleeding is crucial. It can be both diagnostic and therapeutic. Endoscopic techniques for controlling hemorrhage can include sclerotherapy, banding, or balloon tamponade. If these methods are ineffective, or the patient has numerous recurrences, portal shunts can be considered. TIPS have increased in popularity as a method for portal decompression. This can be performed in the acute setting. Surgical shunts are also an option, but are primarily reserved for stable patients with recurrent bleeding episodes and not performed in an acutely unstable patient. Mesocaval shunts connect the SMV to the IVC in a variety of manners. Splenorenal shunts are actually the most common type of shunt. Nonselective shunts that completely divert portal blood flow from the liver can actually increase hepatic encephalopathy. Most surgeons prefer selective shunts, which preserve a component of hepatic blood flow and thus function. Synthetic graft material can be safely used to create the shunts. Postoperative mortality is directly related to the patient’s preprocedure medical condition and degree of hepatic failure (i.e., Child class).